Modelling the Genetic Risk in Age-Related Macular Degeneration
暂无分享,去创建一个
[1] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[2] Johanna M Seddon,et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.
[3] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[4] R. Klein,et al. Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. , 2011, Ophthalmology.
[5] J. Corbo,et al. Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency. , 2011, Human molecular genetics.
[6] Margaret A. Pericak-Vance,et al. Using Genetic Variation and Environmental Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration , 2011, PloS one.
[7] C. Keilhauer,et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). , 2010, Human molecular genetics.
[8] Joan W. Miller. Treatment of age-related macular degeneration: Beyond VEGF , 2010, Japanese Journal of Ophthalmology.
[9] S. Ennis,et al. Determination of a gene and environment risk model for age-related macular degeneration , 2010, British Journal of Ophthalmology.
[10] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[11] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[12] Youping Deng,et al. Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data , 2009, PloS one.
[13] Laura A. Hecker,et al. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[14] T. Meitinger,et al. Age‐related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene , 2009, Human mutation.
[15] Johanna M Seddon,et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.
[16] Daniel E. Weeks,et al. Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers , 2009, PLoS genetics.
[17] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[18] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[19] R. D'Agostino,et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.
[20] J. Giráldez,et al. Ranibizumab for neovascular age-related macular degeneration. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[21] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[22] F. Ferris,et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. , 2007, Archives of ophthalmology.
[23] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[24] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[25] F. Ferris,et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. , 2007, Archives of ophthalmology.
[26] L. Hyman. The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study , 2007 .
[27] I. Deary,et al. Complement C 3 Variant and the Risk of Age-Related Macular Degeneration , 2007 .
[28] K. Eng,et al. Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.
[29] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[30] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[31] Yun Li,et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.
[32] Ewout W Steyerberg,et al. Predictive testing for complex diseases using multiple genes: Fact or fiction? , 2006, Genetics in Medicine.
[33] J. Shao,et al. PSEUDO-R 2 IN LOGISTIC REGRESSION MODEL , 2006 .
[34] Usha Chakravarthy,et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). , 2006, Archives of ophthalmology.
[35] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[36] P.T.V.M. de Jong,et al. Mechanisms of disease: Age-related macular degeneration , 2006 .
[37] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[38] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[39] G. Abecasis,et al. Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.
[40] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[42] Johanna M Seddon,et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.
[43] Lars G Fritsche,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.
[44] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[45] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[46] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[47] G. Cable,et al. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. , 2003, The Journal of the American Board of Family Practice.
[48] J. Habbema,et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.
[49] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[50] A. Hofman,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[51] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[52] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[53] P. Zarembka. Frontiers in econometrics , 1973 .
[54] D. McFadden. Conditional logit analysis of qualitative choice behavior , 1972 .